These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid. Desmond CP; Wilson J; Bailey M; Clark D; Roberts SK Liver Int; 2007 Dec; 27(10):1402-8. PubMed ID: 18036103 [TBL] [Abstract][Full Text] [Related]
28. Sclerosing Cholangitis in Children and Adolescents. Mieli-Vergani G; Vergani D Clin Liver Dis; 2016 Feb; 20(1):99-111. PubMed ID: 26593293 [TBL] [Abstract][Full Text] [Related]
35. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard]. Stiefelhagen P MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736 [No Abstract] [Full Text] [Related]
36. A retrospective single-center review of primary sclerosing cholangitis in children. Miloh T; Arnon R; Shneider B; Suchy F; Kerkar N Clin Gastroenterol Hepatol; 2009 Feb; 7(2):239-45. PubMed ID: 19121649 [TBL] [Abstract][Full Text] [Related]
37. Guidelines for therapy of autoimmune liver disease. Ishibashi H; Komori A; Shimoda S; Gershwin ME Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519 [TBL] [Abstract][Full Text] [Related]
38. Effect of ursodeoxycholic acid and vitamin E in the prevention of liver injury from methotrexate in pediatric leukemia. Bordbar M; Shakibazad N; Fattahi M; Haghpanah S; Honar N Turk J Gastroenterol; 2018 Mar; 29(2):203-209. PubMed ID: 29749328 [TBL] [Abstract][Full Text] [Related]
39. [Clinical manifestation of hepatotoxic effect of cytostatic chemicals]. Polunina TE; Maev IV Eksp Klin Gastroenterol; 2007; (3):52-4. PubMed ID: 17939196 [No Abstract] [Full Text] [Related]
40. Liver involvement in pediatric celiac disease. Anania C; De Luca E; De Castro G; Chiesa C; Pacifico L World J Gastroenterol; 2015 May; 21(19):5813-22. PubMed ID: 26019445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]